pembrolizumab,cisplatin,gemcitabine
merck
['key,note,966', ' gem ', 'pembro']
keynote 966 presented at #aacr2023. gem cddp and pembro in advanced biliary tract cancers first line line.median os was 12 7 months in pembro group versus 10 9 months in the placebo group. #aacr23 #keynote966 #research #cancerresearch #oncologyresearch 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"